The German Cancer Research Center (DKFZ) is expanding its Saxon site. The foundation stone has been laid for a new building on the Oncology Campus of the University Medical Center at TU Dresden, which, according to the announcement, will create unique conditions for the development of future technologies in the prevention, diagnosis and treatment of cancer. The Free State of Saxony is financing the construction with 20 million euros. "Saxony is continuing to invest in cancer research," said Minister President Michael Kretschmer (CDU) at the ceremony. He spoke of a "further milestone in developing new methods for the prevention and treatment of cancer at the highest level and thus saving lives".
Free state relies on high technologies
Michael Baumann, Chairman of the DKFZ Board of Directors, sees "immense potential" for tumor diagnostics and therapy in the technologies of the future. And Dresden, with its University of Excellence TU, the largest industrial cluster for microelectronics in Europe and a particularly start-up-friendly climate, offers "the best conditions for fundamental developments in this field". Kretschmer pointed out that the Free State has relied on a strong research landscape and high technologies for decades. In particular, the connection with future technologies such as smart sensors and AI is "a great benefit for cancer research throughout Germany".
Facilities for patient-oriented cancer research have since been established at the DKFZ site in Dresden, which was founded in 2019, such as a home for the National Center for Tumor Diseases and the German Consortium for Translational Cancer Research. And the new building now under construction is to be extended at a later date, once funding has been approved.
Copyright 2024, dpa (www.dpa.de). All rights reserved
